St.St. Petersburg International ForumPetersburg International Forum

April 25-27, 2012 St. PetersburgSt. Petersburg

THE OUTCOMESTHE OUTCOMES

Pharmacy. Medical Equipment. BiotechnologyPharmacy. Medical Equipment. Biotechnology

IPhEB St. Petersburg International ForumSt. Petersburg International Forum IPhEB is the key event in Russia, dedicated to strategic issues of innovative development of pharmaceutical, biotechnological and medical industry.

The IPhEB 2012 Forum became one of the largest Russian events in the scientific, technical and innovations sphere. The event was mainly focused on elaboration of effective solutions for rapid development of Russian pharmacy and medicine, creation, production and introduction of innovative, high quality medications into clinical practice in order to promote realization of state and private initiatives for development of this extremely important sphere.

2

AAims of the Forum:ims of the Forum:

• To intensify contacts and experience exchange between the major players of the market: heads and experts of companies manufacturing medical or pharmaceutical products, R&D centers, health care facilities; investment, financial and service companies;

• To attract investments to the market; tools and mechanisms of dynamic innovative development;

• To introduce innovative technologies; • To promote locally-manufactured products in international markets

3

Forum IPhEB 2012 is a multi-focused business-oriented event with the following structure:

• Business programme in pharmacy, medicine and biotechnology. • Exhibition of medical, pharmaceutical and laboratory equipment and

technology.

• The tour to Federal Service on Surveillance in Healthcare and Social

Development of the Russian Federation for medicines quality control. • Marchmaking Center • “Presentation zone” for innovative developments

• IPhEB Awards ceremony in nominations: Business project of the year,

Product of the year, IPhEB Science.

4

With the support of:• The Ministry of Industry and Trade of the Russian Federation; • The Chamber of Commerce and Industry of the Russian Federation; • Plenipotentiary Representation of the President of the Russian Federation in the North-

Western Federal District; •

St. Petersburg City Administration

The Forum has gathered heads of executive authorities of all levels, rectors of the largest domestic higher educational institutions and research centers, top managers and experts of pharmacy companies, including MSD, Novartis, Novo-Nordisk, Stada, Philips, AstraZeneca and others.

5

Target audience of the IPhEB 2012:

17%

23%

20%

7%

14%

6%

9%4%

Manufacture of pharmaceuticals, chemical and pharmaceutical industry

Health facilities

Production and delivery of medical, pharmaceutical, laboratory, diagnostic and analyticalequipmentR&D

Pharmacies

Education

Financial institutions, investments (banks, venture funds, etc.)

Other

• The leading companies of medical and pharmaceutical industry;

• The largest R&D institutions;

• Relevant sector committees;

• Investors, financial institutions, investment and insurance companies;

•Representatives of state power.

6

The The Outcomes of the IPhEB-201Outcomes of the IPhEB-20122 Forum Forum

IPhEB International Forum on pharmacy, medical industry and biotechnology was successfully held in St. Petersburg, having gathered over 1,000 participants: heads of federal and regional authorities, defining the industry development policy, the largest higher educational institutions and research centers of the country, as well as companies from 18 regions of Russia and 15 countries.

Promotion of development of the pharmaceutical cluster in St. Petersburg;

Expert discussion of the development prospects in the pharmaceutical sector among more than 1 000 participants;

Attraction of investment to the development of the pharmaceutical cluster;

7

The Forum business programmeThe Forum business programme consisted of 13 topical consisted of 13 topical sessions and master classes on innovative development sessions and master classes on innovative development

of pharmaceutical and medical industry.of pharmaceutical and medical industry.

8

The plenary sessionThe plenary session

The plenary session National priorities in pharmaceutical industry development, held on the second day of the Forum, was opened by Georgy Poltavchenko, St. Petersburg Governor: “I am glad to welcome the participants of the International Forum which is the best site to discuss the issues of domestic pharmacy industry development. This site creates favourable conditions for a dialogue between pharmacists, business and authorities’. Georgy Poltavchenko stressed that pharmacy is not only about business, but also about work for the sake of human well-being.

9

Sergey Tsyb, Director ofSergey Tsyb, Director of department for chemical and technological department for chemical and technological complex and bio-engineering technologies of the Ministry of complex and bio-engineering technologies of the Ministry of

Industry and Trade of the Russian FederationIndustry and Trade of the Russian Federation

Sergey Tsyb in his speech summed up intermediate results of implementing the federal target programme ‘Development Strategy for Pharmaceutical and medical industry of the Russian Federation for the period until 2020 and further outlook’ as one of the most effective tools for complex industry transformation:

“St. Petersburg is demonstrating significant rates in terms of innovative development of pharmacy and medical industry. Attractive investment conditions have been created in the region. The city itself – our northern capital – traditionally possesses the most important resource for such a science-intensive industry as medicine, namely it has human capital. Much has been done and is still being done for the successful formation of one of the first innovative medical and pharmaceutical clusters in Russia, which presupposes the increase in shares of domestic pharmacy products, improvement of their competitiveness and export opportunities. Thus, the region has all prerequisites for successful implementation of projects designed to create pharmaceutical enterprises as well as research and development centers within the framework of the PHARMA 2020 strategy”.

10

PPanel discussion: Optimisation of pricinganel discussion: Optimisation of pricing strategy for vital and strategy for vital and essential medicines: search for effective tools for sustainable essential medicines: search for effective tools for sustainable

development of the Russian pharmaceutical marketdevelopment of the Russian pharmaceutical market

During panel discussion, Dmitry Ter-Stepanov, Head of Department for Competition Development, Ministry for Economic, Development of the Russian Federation, delivered a speech. He informed that an inter-institutional group has been created which is intended to elaborate price calculation method for new medications under supervision of Deputy Minister Mikhail Oseevsky. According to his words, ‘current methods have become outdated and if we keep using them, it may result in erosion of the whole medications groups from the market, mainly the cheap ones, and the fact that the manufacturer has no opportunity to re-register the price leads to the polymorphism in drugs (even the smallest change in the name of pharmaceuticals by adding another definition or a slight replacement of the preparation components allows to register a new price).

11

RRound table Promotion of R&D in the sphere of pharmacy ound table Promotion of R&D in the sphere of pharmacy and biotechnologyand biotechnology

The round table attracted special attention of the participants. Moderator Vitaly Prutskiy, Head of R&D Information in Russia and Eastern Europe, Head of Centre for bio-informatics and predictive medicine in St. Petersburg, set an active tempo to the discussion, having told how quickly – “it took AstraZeneca less than a year” – the company managed to open a Center in St. Petersburg, which will solve no only regional tasks but also will serve the whole world using local resources. Participants of this round table focused their attention on the opportunities and ambitions of Russian R&D market.

12

TTopical session International and regional cooperation in opical session International and regional cooperation in the field of pharmacy and biotechnologythe field of pharmacy and biotechnology

At the topical session, held on the second day of the Forum, Zakhar Golant, Deputy Chairman of Committee for Economic Development, Industrial Policy and Trade of St. Petersburg Government, emphasized that the improvement of international cooperation is necessary to develop the whole region, therefore the Northern capital attaches great importance to the high quality meetings and events industry.

13

IPhEB award in the sphere of pharmacy and biotechnologyIPhEB award in the sphere of pharmacy and biotechnology It is for the first time that an IPhEB award in the sphere of pharmacy and biotechnology was established with the aim to promote development of the latest achievements in the sphere of pharmaceutical, biotechnological and medical technologies.

The awarding ceremony and congratulations to the laureates took place during gala reception on behalf of Georgy Poltavchenko, St. Petersburg Governor on the occasion of the Forum Opening.

14

Biocad with its product Genferone Light Spray became the winner in Product of the year nomination. Dmitry Morozov, Chairman of the Board of Directors received the award.

The nomination for Business project of the year was awarded to the Center of protone radiation therapy of the Center of nuclear medicine at the International Institute of Biologic Systems named after S.M. Berezin. The award was handed to Georgy Andreev, Chief Medical Physicist of the company. The center implements modern methods of nuclear medicine in clinical treatment practice, prolongs lives of oncological patients as well.

IPhEB Science, a special personal award was honoured to Elena Shpakova – a second year graduate student of RAS Institue of High-Molecular Compounds, for the best work in the ‘Chemical synthesis of biologically active substances’ section.

IPhEB award in the sphere of pharmacy and biotechnologyIPhEB award in the sphere of pharmacy and biotechnology

15

Business Matchmaking CenterBusiness Matchmaking Center For three working days of Business Matchmaking Center – a communication site designed to establish new business and partnership contacts – over 70 meetings were registered.

The most significant negotiations were: a meeting of representative of India Ministry of pharmaceutical industry, the administration of the UBM company (Great Britain) and Zakhar Golant, Deputy Chairman of Committee for Economic Development, Industrial Policy and Trade, as well as the meeting of FinnMedi company representatives with Alexander Iova, Head of the Chair of Neurology and Neurosurgery at the Medical Academy of Post-Graduate Education. The Business Matchmaking Center became the major link between the Forum participants and the exhibitors.

16

Exhibition of Medical Pharmaceutical and Laboratory Equipment Exhibition of Medical Pharmaceutical and Laboratory Equipment

within the frameworks of IPhEB Forumwithin the frameworks of IPhEB Forum

Another novelty of the Forum is the Exhibition of Medical Pharmaceutical and Laboratory Equipment within the frameworks of IPhEB Forum, representing the latest achievements, products and services in the sphere of medical, pharmaceutical and biotechnological industry.

17

Exhibition of Medical Pharmaceutical and Laboratory EquipmentExhibition of Medical Pharmaceutical and Laboratory Equipment

The exhibition was participated by the largest Russian and foreign companies, including PHARMEXCIL (India), Favea, Khimexpert, Sartorius IRC and others. A separate exposition was formed by the companies, members of St. Petersburg pharmaceutical and medical industry cluster – Novartis, MSD Pharmaceuticals, Polysan, Samson-Med, Geropharm, LDC MIBS (Treatment and Diagnostics Center of International Institute for Biological systems) and NP Medical and ‘Pharmaceutical Projects. XXI century’.

18

Federal Service on Surveillance in Healthcare and Social Development Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation for medicines quality control.of the Russian Federation for medicines quality control.

A specialised tour took place within the frameworks of the business programme – the IPhEB Forum participants visited a new Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation for medicines quality control.

It is located in the four-storey building and occupies total area of 2,700 sq.m. The participants of this tour observed organisational department, analytical, microbiological and pharmacological laboratories, where 48 high-grade experts work.

“You will not find such a laboratory anywhere in the city. Unique people work here”, Elena Telnova, acting as head of Roszdravnadzor, assures, “there are only three laboratories of such a high level in Russia: in Gudermes, Rostov-on-Don and Krasnoyarsk”. The plans include opening of laboratories in Moscow and other cities. Within the nearest time, a mobile express-laboratory on the basis of St. Petersburg laboratory complex for medicines quality control will start working directly on the inspection facility: pharmacies, drugstores, hospitals, clinics.

19

TestimonialsTestimonials

On the whole, as participants of the business programme and On the whole, as participants of the business programme and exhibition exposition noted, the IPhEB Forum was held successfully.exhibition exposition noted, the IPhEB Forum was held successfully.

Tatiana Mamaeva, Head of Regulatory Department, National Center of Expertise for Phramaceutical Products of the Republic of Kazakhstan,

“I came from Kazakhstan to visit the Forum for the first time. I have great impressions from organisation, discussions and topics. It is undoubtedly an interesting and necessary event. The most currently important topics of the modern pharmaceutical industry, exciting for the specialists of all countries were discussed here. It is a real platform for a dialogue. I wish I could visit all the Forum events”.

20

TestimonialsTestimonials

Robert Rosen, Director General of Selecta (RUS) Company, Bind (RUS):

‘It was a very interesting Forum. Such an event contributes a lot to the future development of science.  The Forum lets us understand and find one’s niche, find research and administrative resources. The Forum provides all the opportunities for future successful work. Success comes with clear purposes’.

21

TestimonialsTestimonials

Martin Schloh, Advisory in the sphere of pharmacy and biotechnology at PricewaterhouseCoopers:

“I would like to thank all event participants and organisers. Special thanks to the Forum interpreters. I saw energy and light in the participants’ eyes’.

22

TestimonialsTestimonials

Sergey Smirnov, Board Chairman of Novo Nordisk LLC:

“St. Petersburg International Forum IPhEB left a very favourable impression by its scale, organisation level, number of participants and topics under discussion. I learned a lot of useful information. A wonderful panel discussion has just finished, where I made a report. And yesterday a plenary session took place, where Georgy Poltavchenko, St. Petersburg Governor, Sergey Tsyb, Director of Department for chemical and technologicalcomplex and bio-engineering technologies of the Ministry of Industry and Trade of the Russian Federation, Elena Telnova, Deputy Head of Federal Service for Supervision of Healthcare and Social Development took part. Participation of such high officials also proves the Forum significance for the Russian pharmacy and biotechnology”.

23

St.St. Petersburg International ForumPetersburg International Forum

April 10-11, 2013 St. PetersburgSt. Petersburg

Pharmacy engineeringPharmacy engineering

Medical equipmentMedical equipment

RadiologyRadiology

BiotechnologyBiotechnology

24

The structure of the IPhEB -2013The structure of the IPhEB -2013

St. Petersburg International Pharmacy Engineering and Biotechnology Forum

International Medical Congress IMedR

International conference for medical radiology

Exhibition of pharmaceutical and laboratory equipment and technology

Exhibition of medical equipment and technics

25

April 10-11, 2013 St. PetersburgSt. Petersburg

St.St. Petersburg International ForumPetersburg International Forum

Pharmacy engineeringPharmacy engineering

Medical equipmentMedical equipment

RadiologyRadiology

BiotechnologyBiotechnology